Faculty: John E. Lincoln
Verification and validation requirements for production and test equipment hardware and software / firmware have always been part of the US FDA’s GMPs. However, with increasing technology, both industry and regulatory agencies expectations have increased. Recent high-profile field problems indicate that V&V activities are not planned or carried out as completely as expected, and may not be fully utilizing the power of current risk management tools, as identified in ISO 14971. The FDA / ICH Q-series provide valuable insights for all regulated industries, not just pharma. The billions of dollars spent by industry annually for V&V are not providing the product safety or efficacy seemingly promised. For most companies, the fixes are not rocket-science, but proper up-front V&V planning and execution. In this webinar we will address both the V&V system as well as consider practical implementation by means of examples.
Areas Covered in the Session :
Who Should Attend: